As of 2025-05-21, the Fair Value of Clinuvel Pharmaceuticals Ltd (CUV.AX) is 14.66 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.74 AUD, the upside of Clinuvel Pharmaceuticals Ltd is 36.51%.
With the market price of 10.74 AUD and our fair value calculation, Clinuvel Pharmaceuticals Ltd (CUV.AX) is a good investment. Investing in CUV.AX stocks now will result in a potential gain of 36.51%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | 15.05 | 24.73 | 20.88 | 30.60 | 35.64 | 25.38 |
| YoY growth | -17.00% | 64.29% | -15.57% | 46.58% | 16.44% | 18.95% |
| Market Cap (mil) | 538.29 |
| P/E | 13.88x |
| Forward P/E | 15.36x |
| EPS | 0.77 |
| Avg earnings growth rate | 18.95% |
| TTM earnings | 38.78 |